The Center for Aquaculture Technologies (CAT), the owner of the largest amount of privately held aquatic animal pathogen containment level 3 (AQC3) space in the world, has opened its third facility in the Canadian province of Prince Edward Island (PEI).
Since first occupying the 46,000 square foot building in the town of Victoria, in the spring of 2020, CAT said it has hired an additional nine staff members to prepare, outfit and operate the facility, which includes a dry lab and office space, the organization reports in a press release. The first health trials began at the end of September.
CAT also operates research aquarium and labs in Souris, PEI, and in San Diego, California.
The AQC3 status allows for the performance of vivo and in vitro studies with both domestic and imported aquatic animals and pathogens, CAT explained in its press release. The high-level designation coupled with its staff’s expertise enables the development of new technologies for the aquaculture industry.
“The acquisition of the Victoria, PEI, facility, supported by substantial investments in wet lab infrastructure and the recruitment of a world-class team to deliver clinical trials, underpin our intention for CAT to be the ‘go-to’ company for aquaculture related contract research services,” said Jason Cleaversmith, general manager and vice president of health and nutrition. “Launching our first trials is an important milestone and signifies to the world that we are open and ready for business.”